Argentine Association of Allergy and Clinical Immunology Congress
Aug 7 - Aug 9, 2025
- Title: CHAPTER-3 Phase 3 Trial Design: Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Extended-Release Tablet for Prophylaxis of Hereditary Angioedema Attacks
Presenter: Ricardo D. Zwiener M.D.
Format: Poster Presentation
Date, time: Saturday, August 9, 9:51 a.m. ART (8:51 a.m. ET) Title: RAPIDe-3 Phase 3 Trial Design: Oral Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks
Presenter: Ricardo D. Zwiener M.D.
Format: Poster Presentation
Date, time: Saturday, August 9, 10:44 a.m. ART (9:44 a.m. ET)